Pharmacokinetic Allometric Scaling of Oligonucleotides

被引:10
|
作者
Mahmood, Iftekhar [1 ]
机构
[1] US FDA, Off Blood Review & Res OBRR, Ctr Biol Evaluat & Res, Rockville, MD USA
关键词
HUMAN DRUG CLEARANCE; OLIGODEOXYNUCLEOTIDE PHOSPHOROTHIOATE GEM-91; MODIFIED ANTISENSE OLIGONUCLEOTIDE; NECROSIS-FACTOR-ALPHA; PHASE-I TRIAL; INTRAVENOUS-INFUSION; PREDICTION; HUMANS; BCL-2; METABOLISM;
D O I
10.1089/nat.2011.0299
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The objective of this study was to evaluate the predictive performance of interspecies scaling of oligonucleotides to predict clearance and volume of distribution at steady state in humans from animal data. The human pharmacokinetic parameters were predicted using 1, 2, or at least 3 animal species. The results of the study indicated that the pharmacokinetic parameters of oligonucleotides can be predicted with reasonable accuracy in humans when at least 3 animal species are employed. On the other hand, allometric scaling based on 1 or 2 species or fixed coefficient or fixed exponent can be erratic and unreliable. Further work should be conducted in this direction.
引用
收藏
页码:315 / 321
页数:7
相关论文
共 50 条
  • [21] Allometric Scaling of Clearance in Paediatric Patients: When Does the Magic of 0.75 Fade?
    Calvier, Elisa A. M.
    Krekels, Elke H. J.
    Valitalo, Pyry A. J.
    Rostami-Hodjegan, Amin
    Tibboel, Dick
    Danhof, Meindert
    Knibbe, Catherijne A. J.
    CLINICAL PHARMACOKINETICS, 2017, 56 (03) : 273 - 285
  • [22] Revisiting the evolutionary origin of allometric metabolic scaling in biology
    Apol, M. Emile F.
    Etienne, Rampal S.
    Olff, Han
    FUNCTIONAL ECOLOGY, 2008, 22 (06) : 1070 - 1080
  • [23] Non-universal Interspecific Allometric Scaling of Metabolism
    da Silva, Jafferson K. L.
    Barbosa, Lauro A.
    BRAZILIAN JOURNAL OF PHYSICS, 2009, 39 (04) : 699 - 706
  • [24] Allometric scaling of xenobiotic clearance: Uncertainty versus universality
    Hu, TM
    Hayton, WL
    AAPS PHARMSCI, 2001, 3 (04):
  • [25] Allometric scaling of xenobiotic clearance: Uncertainty versus universality
    Teh-Min Hu
    William L. Hayton
    AAPS PharmSci, 3 (4):
  • [26] A systematic review of allometric scaling exponents for IgG mAbs
    Rowland, Simon Peter
    Nixon, Emma
    Mohan, Krithika
    Wang, Qianwen
    Yates, James W. T.
    XENOBIOTICA, 2024, 54 (09) : 609 - 614
  • [27] The natural selection of metabolism explains curvature in allometric scaling
    Witting, Lars
    OIKOS, 2018, 127 (07) : 991 - 1000
  • [28] Allometric scaling and Bayesian priors for annual survival of birds and mammals
    McCarthy, Michael A.
    Citroen, Rebecca
    McCall, Sarah C.
    AMERICAN NATURALIST, 2008, 172 (02) : 216 - 222
  • [29] Calculation of a First-In-Man Dose of 7-O-Succinyl Macrolactin A Based on Allometric Scaling of Data from Mice, Rats, and Dogs
    Noh, Keumhan
    Kang, Wonku
    BIOMOLECULES & THERAPEUTICS, 2017, 25 (06) : 648 - 658
  • [30] Pharmacokinetics and Interspecies Allometric Scaling of ST-246, an Oral Antiviral Therapeutic for Treatment of Orthopoxvirus Infection
    Amantana, Adams
    Chen, Yali
    Tyavanagimatt, Shanthakumar R.
    Jones, Kevin F.
    Jordan, Robert
    Chinsangaram, Jarasvech
    Bolken, Tove C.
    Leeds, Janet M.
    Hruby, Dennis E.
    PLOS ONE, 2013, 8 (04):